LifeStance Health Group, Inc. (LFST) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $7.55 (-0.26%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 2, 2026 | David Larsen | BTIG | $11.00 | +45.7% |
| Jan 8, 2026 | Steve Dechert | KeyBanc | $8.50 | +12.6% |
| Jan 8, 2026 | Richard Close | Canaccord Genuity | $9.00 | +19.2% |
| Dec 8, 2025 | Peter Warendorf | Barclays | $8.00 | +6.0% |
| May 27, 2025 | Kevin Caliendo | UBS | $8.50 | +12.6% |
Top Analysts Covering LFST
LFST vs Sector & Market
| Metric | LFST | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 8 | 8 | 18 |
| Target Upside | +23.2% | +1150.2% | +14.9% |
| P/E Ratio | 377.50 | 6.52 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.62B | $1.64B | $1.65B | 7 |
| 2027-03-31 | $431M | $438M | $448M | 2 |
| 2027-06-30 | $446M | $454M | $464M | 2 |
| 2027-09-30 | $468M | $476M | $487M | 2 |
| 2027-12-31 | $491M | $499M | $510M | 2 |
| 2028-03-31 | $491M | $499M | $511M | 1 |
| 2028-06-30 | $507M | $515M | $527M | 1 |
| 2028-09-30 | $529M | $538M | $551M | 1 |
| 2028-12-31 | $554M | $563M | $576M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.06 | $0.07 | $0.08 | 4 |
| 2027-03-31 | $0.05 | $0.06 | $0.06 | 1 |
| 2027-06-30 | $0.06 | $0.06 | $0.06 | 1 |
| 2027-09-30 | $0.06 | $0.07 | $0.07 | 1 |
| 2027-12-31 | $0.08 | $0.08 | $0.08 | 1 |
| 2028-03-31 | $0.09 | $0.09 | $0.09 | 1 |
| 2028-06-30 | $0.10 | $0.10 | $0.10 | 1 |
| 2028-09-30 | $0.10 | $0.10 | $0.11 | 1 |
| 2028-12-31 | $0.12 | $0.12 | $0.13 | 1 |
Frequently Asked Questions
What is the analyst consensus for LFST?
The consensus among 8 analysts covering LifeStance Health Group, Inc. (LFST) is Buy with an average price target of $9.30.
What is the highest price target for LFST?
The highest price target for LFST is $11.00, set by David Larsen at BTIG on 2026-02-02.
What is the lowest price target for LFST?
The lowest price target for LFST is $8.00, set by Peter Warendorf at Barclays on 2025-12-08.
How many analysts cover LFST?
8 analysts have issued ratings for LifeStance Health Group, Inc. in the past 12 months.
Is LFST a buy or sell right now?
Based on 8 analyst ratings, LFST has a consensus rating of Buy (2.00/5) with a +23.2% upside to the consensus target of $9.30.
What are the earnings estimates for LFST?
Analysts estimate LFST will report EPS of $0.07 for the period ending 2026-12-31, with revenue estimated at $1.64B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.